Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Last week, readers were most interested in a story about QuidelOrtho's ongoing restructuring to support profitability.

The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

The UK-based firm is developing its initial panel tests for Gram-negative bacteria with tests for Gram-positive bacteria and ...

NEW YORK – Lumea and Caris Life Sciences said on Thursday that they have agreed to make Caris' sequencing-based urology tools available through Lumea's BxLink digital pathology platform. Under the ...

Clinical Diagnostics Growth Drives Rise in Qiagen's Q3 Revenues ...

NEW YORK – Israel Institute of Technology spinout MetaSight Diagnostics announced on Wednesday that it has closed an $8 million oversubscribed Series A financing round. The round was led by new ...